Venture Capital

Life Sciences Venture Investor Foresite Capital Raises $969 Million

Read more at www.wsj.com

Life sciences venture investor Foresite Capital has raised $969 million through two new funds after placing successful bets on emerging industries such as biotechnology, genomics and synthetic biology.

San Francisco-based Foresite raised $775 million for its latest venture fund, Foresite Capital Fund V LP, and $193.8 million for another vehicle, Foresite Capital Opportunity Fund V LP, which will enable it to make additional investments in select companies from the venture fund, a spokesman said.

Foresite,…

Read more at www.wsj.com

Show More

Related Articles

Back to top button